Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Baxter
McKinsey
Merck
Boehringer Ingelheim

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

BLEOMYCIN SULFATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Bleomycin Sulfate, and what generic alternatives are available?

Bleomycin Sulfate is a drug marketed by Cipla, Fresenius Kabi Usa, Hong Kong, Hospira, Pharmachemie Bv, Teva Parenteral, Teva Pharms Usa, and West-ward Pharms Int. and is included in eight NDAs.

The generic ingredient in BLEOMYCIN SULFATE is bleomycin sulfate. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.

Drug patent expirations by year for BLEOMYCIN SULFATE
Recent Clinical Trials for BLEOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The EMMES CorporationPhase 1
AIDS Malignancy ConsortiumPhase 1
University of ArkansasPhase 1

See all BLEOMYCIN SULFATE clinical trials

Pharmacology for BLEOMYCIN SULFATE
Medical Subject Heading (MeSH) Categories for BLEOMYCIN SULFATE
Synonyms for BLEOMYCIN SULFATE
(3-(2'-(1-(6-amino-2-(3-amino-1-((2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidin-4-yl)-3-((((2R,3S,4S,5S,6S)-3-(((2R,3S,4S,5R,6R)-4-(carbamoyloxy)-3,5-dihydroxy-6-(hyd
11056-06-7
11056-06-7 (Parent)
1400-95-9
37208-04-1
37293-16-6
37353-43-8
9041-93-4
9041-93-4 (sulfate (salt))
AC-5259
AC1L2I4G
AC1NSEJD
AKOS015896273
AKOS022190415
AKOS025402121
AN-11149
BC683933
Blenoxane
Bleo
Bleocin
Bleomicin
Bleomicina
Bleomicina [INN-Spanish]
bleomycin
Bleomycin (sulfate)
Bleomycin [INN:BAN]
Bleomycin [INN]
Bleomycin A(2)
bleomycin a2
Bleomycin antibiotic complex
Bleomycin B(2)
Bleomycin sulfate (salt)
Bleomycin sulfate [Bleomycins]
Bleomycin sulfate [USAN:JAN]
Bleomycin sulfate [USAN:USP:JAN]
Bleomycin sulfate salt
Bleomycin sulphate
Bleomycin, sulfate
Bleomycin, sulfate (salt)
Bleomycine
Bleomycine [INN-French]
Bleomycins
Bleomycins (complex consisting of bleomycin A2 and B2)
Bleomycinum
Bleomycinum [INN-Latin]
Blexane
BLM
C55H85N17O21S3
C55H86N17O21S3.O4S
CCRIS 2470
CCRIS 2754
CS-3071
DB00290
DRG-0045 (mixed bleomycins)
EINECS 232-925-2
EX-A1960
HSDB 3208
HY-17565
I06-2155
KB-286964
LMPK14000006
LS-44912
LS-524
MolPort-008-155-965
NDC 0015-3010
NSC 125066
PubChem18938
roxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)(1H-imidazol-5-yl)methyl)-7-hydroxy-11-(1-hydroxyethyl)-6,8-dimethyl-1,4,9,12-tetraoxo-2,5,10,13-te
s1214
SCHEMBL1599
SCHEMBL1648595
SR-01000941586
SR-01000941586-2
SW222226-1
traazapentadecan-15-yl)-[2,4'-bithiazole]-4-carboxamido)propyl)dimethylsulfonium hydrogen sulfate

US Patents and Regulatory Information for BLEOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 209439-001 Mar 11, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 065031-002 Mar 10, 2000 AP RX No No   Start Trial   Start Trial   Start Trial
Hong Kong BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 205030-001 Apr 20, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 065033-002 Jun 27, 2000 AP RX No No   Start Trial   Start Trial   Start Trial
Pharmachemie Bv BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 065201-001 Dec 13, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Colorcon
Johnson and Johnson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.